Due to the site upgrade, your MY ACCOUNT logins will need to be updated. Please access Forgot Your Password to make this change. If you do not have an account, click here.

L-Carnitine supplementation protects against liver cancer in an animal study

Apr 06, 2009

Long term supplementation with the amino acid L-Carnitine protected rats from cancer of the liver. For 8 weeks the researchers supplemented 20 rats with L-Carnitine, and 20 rats with synthetic D-Carnitine and the drug mildronate to cause a Carnitine deficiency. After two weeks of supplementation, ten rats in each group plus 10 non-supplemented rats received an injection of the dangerous cancer causing chemical diethylnitrosamine (DENA) followed two weeks later by a dose of toxic carbon tetrachloride. Ten un-supplemented control rats were injected with normal saline. At the end of the treatment period, increased liver enzymes, liver degeneration, and precancerous liver lesions were observed among the DENA-treated but un-supplemented and L-Carnitine deficient rats. These changes were prevented in DENA-treated animals that were supplemented with L-Carnitine. While DENA administration resulted in increased oxidative stress and a reduction in glutathione and antioxidant enzymes in the livers of un-supplemented and L-Carnitine-deficient mice, the effect was modified by L-Carnitine. L-Carnitine may be able to decrease liver toxicity caused by a variety of highly toxic chemicals. The study is published in the March 21, 2009 issue of the World Journal of Gastroenterology.